Analysis

Madrigal Pharmaceuticals Shares Surge 268% on Positive NASH Breakthrough

12/20/2022

News

3 Reasons Why Buying Madrigal Pharmaceuticals Today Is a Wise Move

When a company's shares shoot up 82% in 12 months, investors clearly think it's a good time to be a shareholder -- and that's exactly what's happened to the stock of Madrigal Pharmaceuticals (MDGL 5.53%). Earlier this year, the up-and-coming biotech received approval of a pioneering liver-disease treatment.

11/23/2024

Madrigal (MDGL) Just Flashed Golden Cross Signal: Do You Buy?

Madrigal Pharmaceuticals, Inc. (MDGL) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, MDGL's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.

11/22/2024

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is Madrigal Pharmaceuticals, Inc. (MDGL) a buy, sell, or hold?

Madrigal Pharmaceuticals, Inc. (MDGL) can sell. Click on Rating Page for detail.

What is Madrigal Pharmaceuticals, Inc.'s stock price?

The price of Madrigal Pharmaceuticals, Inc. (MDGL) is 318.44 and it was updated on 2024-12-10 01:08:59.

Is Madrigal Pharmaceuticals, Inc. (MDGL) overvalued or undervalued?

Currently Madrigal Pharmaceuticals, Inc. (MDGL) is in undervalued.

News

From:

To:

News
Wall Street Analysts Believe Madrigal (MDGL) Could Rally 26.44%: Here's is How to Trade The average of price targets set by Wall Street analysts indicates a potential upside of 26.4% in Madrigal (MDGL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. Mon, Nov. 18, 2024
Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance Madrigal, Corcept, Catalyst Larimar and Theravance have been highlighted in this Industry Outlook article. Mon, Nov. 11, 2024
1 Growing Biotech Stock to Buy Today With $1,000 and Hold for 5 Years or More There's a bright future ahead for this company. Sun, Nov. 10, 2024
5 Small Drug Stocks to Buy as Trump Gets Re-Elected Innovation is at its peak for the Zacks Medical-Drugs industry. MDGL, CORT, CPRX, LRMR and TBPH may prove to be good additions to one's portfolio. Fri, Nov. 08, 2024
Here's Why Madrigal (MDGL) is a Great Momentum Stock to Buy Does Madrigal (MDGL) have what it takes to be a top stock pick for momentum investors? Let's find out. Thu, Nov. 07, 2024

Transcripts

Transcipts Data
Madrigal Pharmaceuticals, Inc. (MDGL) on Q3 2024 Results - Earnings Call Transcript SA Transcripts Thu, Oct. 31, 2024
Madrigal Pharmaceuticals, Inc. (MDGL) on Q2 2024 Results - Earnings Call Transcript SA Transcripts Wed, Aug. 07, 2024
Madrigal Pharmaceuticals, Inc. (MDGL) on Q1 2024 Results - Earnings Call Transcript SA Transcripts Tue, May. 07, 2024
Madrigal Pharmaceuticals, Inc. (MDGL) on Q1 2022 Results - Earnings Call Transcript SA Transcripts Mon, May. 09, 2022

SEC Filings

SEC Filings
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 12/05/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/27/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/22/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 11/14/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G SEC Filings 11/14/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/08/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/05/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - S-8 SEC Filings 10/31/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 10/31/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 10/31/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 09/17/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 09/11/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 08/19/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 3 SEC Filings 08/15/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 08/07/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 08/07/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 06/27/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 06/27/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 06/18/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 06/14/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 06/13/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 05/23/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 05/16/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - S-3ASR SEC Filings 05/07/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 05/07/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 05/07/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B3 SEC Filings 05/07/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 05/07/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - DEFA14A SEC Filings 04/29/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - DEF 14A SEC Filings 04/29/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - ARS SEC Filings 04/29/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 04/10/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 04/05/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 04/03/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 04/02/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 03/25/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 03/25/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 3 SEC Filings 03/21/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 03/20/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 03/20/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 03/18/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 03/15/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 02/28/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-K - Current report SEC Filings 02/28/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 02/14/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 02/13/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 01/29/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 01/25/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 01/22/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 01/18/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 01/08/2024
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 12/18/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 12/14/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 12/13/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 12/11/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 12/06/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 12/01/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/22/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 3 SEC Filings 11/22/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 11/21/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/21/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/15/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G SEC Filings 11/13/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 11/06/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 11/06/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 10/10/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 10/05/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 10/05/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 10/02/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 10/02/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 09/28/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 09/25/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 09/14/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 09/13/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 09/13/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 3 SEC Filings 09/13/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - S-8 SEC Filings 09/11/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G SEC Filings 09/08/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 08/08/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 08/08/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B3 SEC Filings 08/08/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 08/08/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 07/17/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 06/30/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D SEC Filings 06/20/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 06/20/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 06/20/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 3 SEC Filings 06/20/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 05/09/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 05/09/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 05/09/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - DEFA14A SEC Filings 05/01/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - DEF 14A SEC Filings 05/01/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - PRE 14A SEC Filings 04/21/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-K/A - Current report SEC Filings 03/03/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 03/02/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 02/23/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-K - Current report SEC Filings 02/23/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 02/14/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 02/09/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 02/06/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G SEC Filings 02/02/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 02/01/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 01/19/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 01/18/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 01/10/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 01/06/2023
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 12/28/2022
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 12/23/2022
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 12/23/2022
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 12/19/2022
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 11/03/2022
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 11/03/2022
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 08/12/2022
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 08/04/2022
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 08/04/2022
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 06/21/2022
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 06/17/2022
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G SEC Filings 05/19/2022
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 05/09/2022
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 05/09/2022
Madrigal Pharmaceuticals, Inc. (MDGL) - DEFA14A SEC Filings 05/02/2022
Madrigal Pharmaceuticals, Inc. (MDGL) - DEF 14A SEC Filings 05/02/2022
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 02/24/2022
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 02/24/2022
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-K - Current report SEC Filings 02/24/2022
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G SEC Filings 02/15/2022
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 02/14/2022
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G SEC Filings 02/14/2022
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 02/11/2022
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 02/10/2022
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 02/04/2022
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 02/03/2022
Madrigal Pharmaceuticals, Inc. (MDGL) - 5 SEC Filings 02/02/2022
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 12/07/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 12/07/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 11/04/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 11/04/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/03/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 08/05/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 08/05/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 08/04/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - 3 SEC Filings 08/04/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 07/09/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - S-8 SEC Filings 06/29/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 06/21/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 06/21/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - S-3ASR SEC Filings 06/01/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 06/01/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 06/01/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 05/19/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - 3 SEC Filings 05/19/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 05/18/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 05/06/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 05/06/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - DEFA14A SEC Filings 04/30/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - DEF 14A SEC Filings 04/30/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 02/25/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-K - Current report SEC Filings 02/25/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 02/23/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 02/16/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 02/12/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G SEC Filings 02/12/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - 5 SEC Filings 02/11/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 02/10/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 02/04/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G SEC Filings 02/02/2021
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 12/01/2020
Madrigal Pharmaceuticals, Inc. (MDGL) - S-8 SEC Filings 11/05/2020
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 11/05/2020
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 11/05/2020
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 11/05/2020
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 09/08/2020
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 09/04/2020
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 08/19/2020
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 08/10/2020
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 08/06/2020
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 08/06/2020
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 06/18/2020
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 06/18/2020
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 06/01/2020
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 05/29/2020
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 05/07/2020
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 05/07/2020
Madrigal Pharmaceuticals, Inc. (MDGL) - DEF 14A SEC Filings 04/29/2020
Madrigal Pharmaceuticals, Inc. (MDGL) - 3 SEC Filings 04/02/2020
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 03/05/2020
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 02/26/2020
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 02/26/2020
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-K - Current report SEC Filings 02/26/2020
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 02/14/2020
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G SEC Filings 02/11/2020
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G SEC Filings 01/28/2020
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 12/13/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - 4/A SEC Filings 12/13/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 12/13/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 12/12/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B7 SEC Filings 12/12/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 12/10/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 11/06/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 11/06/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 10/17/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 08/07/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 08/07/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 07/11/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 07/11/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 07/02/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 07/01/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - 3 SEC Filings 07/01/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - DEFA14A SEC Filings 05/15/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - DEF 14A SEC Filings 05/15/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 05/08/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - 3 SEC Filings 05/08/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 05/08/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-K/A - Current report SEC Filings 04/30/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - CT ORDER SEC Filings 03/12/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 03/11/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 02/27/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-K - Current report SEC Filings 02/27/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 02/14/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 02/13/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G SEC Filings 02/13/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G SEC Filings 02/07/2019
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/23/2018
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/19/2018
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/14/2018
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 11/06/2018
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 11/06/2018
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 09/19/2018
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G SEC Filings 08/10/2018
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 08/07/2018
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 08/07/2018
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 06/22/2018
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 06/21/2018
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 06/13/2018
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 06/12/2018
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 06/08/2018
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 06/07/2018
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 06/06/2018
Madrigal Pharmaceuticals, Inc. (MDGL) - S-3ASR SEC Filings 06/05/2018
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 05/31/2018
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 05/08/2018
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 05/08/2018
Madrigal Pharmaceuticals, Inc. (MDGL) - S-8 SEC Filings 04/27/2018
Madrigal Pharmaceuticals, Inc. (MDGL) - DEFA14A SEC Filings 04/27/2018
Madrigal Pharmaceuticals, Inc. (MDGL) - DEF 14A SEC Filings 04/27/2018
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 03/13/2018
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-K - Current report SEC Filings 03/13/2018
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 03/05/2018
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G SEC Filings 02/13/2018
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 12/21/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 12/20/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 12/18/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 11/09/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 11/09/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 08/24/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 08/23/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 08/22/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 08/10/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 08/10/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - EFFECT SEC Filings 07/26/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B3 SEC Filings 07/26/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - UPLOAD SEC Filings 07/21/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - CORRESP SEC Filings 07/21/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - S-3 SEC Filings 07/17/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - D SEC Filings 07/05/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 07/05/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 06/30/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 06/21/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 06/01/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 05/11/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 05/11/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - DEF 14A SEC Filings 04/28/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 04/03/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 03/31/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q/A - Quarterly Report SEC Filings 03/31/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-K - Current report SEC Filings 03/31/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - CT ORDER SEC Filings 03/15/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 03/06/2017
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/21/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 3 SEC Filings 11/21/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q/A - Quarterly Report SEC Filings 11/16/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 11/14/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 11/14/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 4/A SEC Filings 11/04/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 10/24/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 09/30/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K/A - Current report SEC Filings 09/02/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 4/A SEC Filings 08/23/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 08/11/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 08/01/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 3 SEC Filings 07/29/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 07/26/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 07/26/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 3 SEC Filings 07/26/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 07/22/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 07/22/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - S-8 SEC Filings 07/21/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 07/20/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - DEFA14A SEC Filings 07/06/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - DEFA14A SEC Filings 06/14/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - DEFM14A SEC Filings 06/08/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - DEFA14A SEC Filings 06/08/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 06/08/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - UPLOAD SEC Filings 06/03/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 06/03/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - DEFA14A SEC Filings 06/02/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 06/02/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - CORRESP SEC Filings 06/01/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - PREM14A SEC Filings 05/19/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 05/10/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - DEFA14A SEC Filings 05/03/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 05/03/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-K/A - Current report SEC Filings 04/29/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D SEC Filings 04/28/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 04/22/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 04/15/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - DEFA14A SEC Filings 04/15/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 04/15/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - DEFA14A SEC Filings 04/14/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 04/14/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-K - Current report SEC Filings 03/15/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 03/01/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 01/05/2016
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 12/15/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 12/09/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 12/09/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 12/09/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 12/08/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 12/07/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 12/03/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 12/01/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/30/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/24/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 11/23/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/20/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/19/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/17/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 11/13/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 4/A SEC Filings 11/13/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/12/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 11/05/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/05/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 3 SEC Filings 11/05/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 11/05/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 10/29/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 10/22/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - EFFECT SEC Filings 10/19/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 10/16/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 10/16/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - CORRESP SEC Filings 10/14/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 10/06/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 10/02/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 09/18/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - UPLOAD SEC Filings 08/14/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - S-8 SEC Filings 08/06/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - S-3 SEC Filings 08/06/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 08/06/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 07/07/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 07/06/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 07/02/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 06/15/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 06/08/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 05/07/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - ARS SEC Filings 05/06/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - DEF 14A SEC Filings 04/30/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 04/27/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 04/10/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 04/08/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 04/06/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 04/01/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 04/01/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 03/30/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - S-8 SEC Filings 03/12/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-K - Current report SEC Filings 03/12/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 03/06/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 03/04/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 02/05/2015
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 12/10/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 3 SEC Filings 12/10/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 12/04/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 11/06/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 10/06/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 10/01/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 09/04/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 3 SEC Filings 09/04/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 08/06/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 08/06/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 07/21/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 07/18/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 07/18/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 07/03/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 06/27/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 06/17/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - EFFECT SEC Filings 05/15/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - POS AM SEC Filings 05/08/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 05/08/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 05/08/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 05/08/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - ARS SEC Filings 05/07/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - DEF 14A SEC Filings 04/30/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 04/23/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 04/14/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 04/14/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 04/14/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 03/20/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - S-8 SEC Filings 03/11/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-K - Current report SEC Filings 03/11/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 03/05/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 3 SEC Filings 03/05/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 03/04/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 5 SEC Filings 02/13/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 3 SEC Filings 01/13/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 01/07/2014
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 12/20/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 12/20/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 3 SEC Filings 12/20/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 12/17/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 12/16/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 12/16/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 12/02/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 11/18/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/15/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 11/14/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 11/14/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 11/12/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 11/04/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 10/30/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 09/16/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 09/11/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 08/01/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 07/29/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 07/10/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 07/03/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 07/01/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 06/28/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 06/27/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 06/25/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 06/24/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 06/20/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 06/17/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 06/17/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 06/07/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 06/06/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 06/03/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - ARS SEC Filings 05/08/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 05/06/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B2 SEC Filings 05/03/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - EFFECT SEC Filings 05/02/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 04/30/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - DEF 14A SEC Filings 04/29/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - CORRESP SEC Filings 04/29/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - PRE 14A SEC Filings 04/17/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 04/01/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - UPLOAD SEC Filings 03/19/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - S-8 SEC Filings 03/14/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - S-3 SEC Filings 03/14/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-K - Current report SEC Filings 03/14/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 03/13/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 03/13/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 3 SEC Filings 03/13/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 03/08/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 03/07/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 02/14/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 5 SEC Filings 02/14/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 01/24/2013
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 12/20/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 12/18/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 12/14/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 12/13/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 12/13/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G SEC Filings 12/10/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 12/03/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 11/16/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/14/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/13/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 11/06/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 10/01/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 09/17/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 08/09/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 08/02/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 07/27/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 07/27/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 07/26/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 07/26/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 07/03/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 07/03/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 07/02/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 06/28/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 06/20/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 06/19/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 06/06/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - ARS SEC Filings 05/15/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - S-8 SEC Filings 05/03/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 05/03/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 05/03/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - DEF 14A SEC Filings 04/27/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 04/05/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 03/08/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 03/05/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - CT ORDER SEC Filings 02/24/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-K - Current report SEC Filings 02/22/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 02/15/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 02/14/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 5 SEC Filings 02/14/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G SEC Filings 02/09/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 01/26/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 01/11/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 01/10/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 01/06/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 01/06/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 01/05/2012
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 12/09/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 12/01/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 12/01/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/29/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/25/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/22/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 11/16/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 11/03/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 09/13/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 09/07/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 09/06/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 08/30/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 08/24/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - EFFECT SEC Filings 08/22/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 08/22/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 08/19/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B2 SEC Filings 08/19/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - CT ORDER SEC Filings 08/12/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 08/10/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - CT ORDER SEC Filings 08/09/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - S-3 SEC Filings 08/04/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 08/04/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 07/21/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 07/07/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 07/06/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 06/27/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 06/15/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 06/06/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - ARS SEC Filings 05/05/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 05/05/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - S-8 SEC Filings 05/02/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - DEF 14A SEC Filings 04/29/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 04/26/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 04/22/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 04/18/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 04/18/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 04/15/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 04/15/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 04/04/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 03/15/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-K - Current report SEC Filings 03/11/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 03/03/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 03/01/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 02/14/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 5 SEC Filings 02/14/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 02/09/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 01/14/2011
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/30/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 3 SEC Filings 11/30/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 11/12/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 11/12/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 11/12/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/12/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 11/04/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 10/05/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 10/05/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 09/30/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 09/30/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 3 SEC Filings 09/30/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 09/17/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 09/15/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 09/15/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 08/31/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 08/20/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 08/09/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 08/06/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 07/06/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 06/21/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 06/16/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 06/14/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - CT ORDER SEC Filings 06/10/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 06/10/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - ARS SEC Filings 05/10/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 05/04/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - DEF 14A SEC Filings 04/30/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-K - Current report SEC Filings 03/11/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 03/03/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 02/12/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 5/A SEC Filings 02/12/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 5 SEC Filings 02/12/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 02/11/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 01/15/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D/A SEC Filings 01/12/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 01/12/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 01/08/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 01/08/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B5 SEC Filings 01/07/2010
Madrigal Pharmaceuticals, Inc. (MDGL) - CT ORDER SEC Filings 11/13/2009
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-K/A - Current report SEC Filings 11/10/2009
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 11/04/2009
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 10/27/2009
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 08/26/2009
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 08/07/2009
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 08/04/2009
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 07/13/2009
Madrigal Pharmaceuticals, Inc. (MDGL) - 3 SEC Filings 07/13/2009
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 07/06/2009
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 06/19/2009
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 06/15/2009
Madrigal Pharmaceuticals, Inc. (MDGL) - ARS SEC Filings 05/07/2009
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 05/07/2009
Madrigal Pharmaceuticals, Inc. (MDGL) - DEF 14A SEC Filings 04/30/2009
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 04/17/2009
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 04/14/2009
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 03/26/2009
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-K - Current report SEC Filings 03/26/2009
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 03/19/2009
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 03/18/2009
Madrigal Pharmaceuticals, Inc. (MDGL) - NT 10-K - Current report SEC Filings 03/17/2009
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 02/27/2009
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 02/13/2009
Madrigal Pharmaceuticals, Inc. (MDGL) - 5 SEC Filings 02/13/2009
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 01/06/2009
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 12/30/2008
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 11/13/2008
Madrigal Pharmaceuticals, Inc. (MDGL) - EFFECT SEC Filings 08/29/2008
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B2 SEC Filings 08/29/2008
Madrigal Pharmaceuticals, Inc. (MDGL) - CT ORDER SEC Filings 08/27/2008
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 08/13/2008
Madrigal Pharmaceuticals, Inc. (MDGL) - S-3 SEC Filings 08/07/2008
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 08/07/2008
Madrigal Pharmaceuticals, Inc. (MDGL) - S-8 SEC Filings 08/06/2008
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 08/06/2008
Madrigal Pharmaceuticals, Inc. (MDGL) - 3 SEC Filings 08/06/2008
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D SEC Filings 06/20/2008
Madrigal Pharmaceuticals, Inc. (MDGL) - CT ORDER SEC Filings 06/20/2008
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 06/13/2008
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 06/02/2008
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 05/20/2008
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 05/14/2008
Madrigal Pharmaceuticals, Inc. (MDGL) - ARS SEC Filings 05/09/2008
Madrigal Pharmaceuticals, Inc. (MDGL) - DEF 14A SEC Filings 04/29/2008
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 04/29/2008
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 04/18/2008
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-K - Current report SEC Filings 03/20/2008
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 02/29/2008
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G/A SEC Filings 02/14/2008
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G SEC Filings 02/14/2008
Madrigal Pharmaceuticals, Inc. (MDGL) - 5 SEC Filings 02/14/2008
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 11/26/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - 144 SEC Filings 11/16/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - 144 SEC Filings 11/14/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 11/13/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - 144 SEC Filings 10/16/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 10/12/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 08/06/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 07/23/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 07/03/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13D SEC Filings 06/18/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 06/12/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-Q - Quarterly Report SEC Filings 05/07/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - S-8 SEC Filings 04/05/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - 3/A SEC Filings 04/03/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - 10-K - Current report SEC Filings 03/28/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-K - Current report SEC Filings 03/02/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 02/28/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - SC 13G SEC Filings 02/16/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - 4 SEC Filings 02/13/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - EFFECT SEC Filings 02/07/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - 424B4 SEC Filings 02/07/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - EFFECT SEC Filings 02/06/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - POS AM SEC Filings 02/06/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - FWP SEC Filings 02/06/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - CERTNAS SEC Filings 02/06/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - S-1/A SEC Filings 02/05/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - 3 SEC Filings 02/05/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - CORRESP SEC Filings 02/01/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - 8-A12B SEC Filings 01/26/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - S-1/A SEC Filings 01/23/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - UPLOAD SEC Filings 01/18/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - S-1/A SEC Filings 01/04/2007
Madrigal Pharmaceuticals, Inc. (MDGL) - UPLOAD SEC Filings 12/19/2006
Madrigal Pharmaceuticals, Inc. (MDGL) - S-1/A SEC Filings 12/01/2006
Madrigal Pharmaceuticals, Inc. (MDGL) - S-1 SEC Filings 11/22/2006
Madrigal Pharmaceuticals, Inc. (MDGL) - RW SEC Filings 06/13/2005
Madrigal Pharmaceuticals, Inc. (MDGL) - S-1/A SEC Filings 04/29/2005
Madrigal Pharmaceuticals, Inc. (MDGL) - S-1/A SEC Filings 04/22/2005
Madrigal Pharmaceuticals, Inc. (MDGL) - S-1/A SEC Filings 03/17/2005
Madrigal Pharmaceuticals, Inc. (MDGL) - S-1/A SEC Filings 02/23/2005
Madrigal Pharmaceuticals, Inc. (MDGL) - S-1 SEC Filings 01/18/2005
Madrigal Pharmaceuticals, Inc. (MDGL) - REGDEX/A SEC Filings 12/07/2004
Madrigal Pharmaceuticals, Inc. (MDGL) - REGDEX SEC Filings 11/01/2004
Madrigal Pharmaceuticals, Inc. (MDGL) - REGDEX SEC Filings 09/14/2004
Madrigal Pharmaceuticals, Inc. (MDGL) - REGDEX/A SEC Filings 02/25/2004
Madrigal Pharmaceuticals, Inc. (MDGL) - REGDEX SEC Filings 10/03/2003
Madrigal Pharmaceuticals, Inc. (MDGL) - REGDEX/A SEC Filings 04/21/2003
Madrigal Pharmaceuticals, Inc. (MDGL) - REGDEX SEC Filings 10/07/2002
Madrigal Pharmaceuticals, Inc. (MDGL) - REGDEX SEC Filings 05/31/2002

Press Releases

StockPrice Release
Madrigal pharmaceuticals, inc. announces participation at three upcoming investor conferences 11/06/2024
Madrigal pharmaceuticals to present multiple rezdiffra™ (resmetirom) abstracts in nash/mash at the aasld liver meeting® 10/30/2024
Madrigal pharmaceuticals completes enrollment of clinical outcomes study of resmetirom in patients with compensated nash/mash cirrhosis 10/21/2024
Madrigal pharmaceuticals to release third-quarter 2024 financial results and host webcast on october 31, 2024 10/18/2024
Madrigal pharmaceuticals to participate in the h.c. wainwright & co. 8th annual mash investor conference 10/02/2024
Madrigal pharmaceuticals reports second-quarter 2024 financial results and provides corporate updates 08/07/2024
Madrigal pharmaceuticals appoints shannon kelley as general counsel 08/02/2024
Madrigal pharmaceuticals to release second-quarter 2024 financial results and host webcast on august 7, 2024 07/24/2024
Madrigal pharmaceuticals announces new data from the phase 3 maestro-nash study of rezdiffra™ (resmetirom) presented at the easl congress 06/06/2024
Madrigal pharmaceuticals reports first-quarter 2024 financial results and provides corporate updates 05/07/2024
Madrigal statement on the passing of dr. stephen harrison 04/24/2024
Madrigal pharmaceuticals reports inducement grants under nasdaq listing rule 5635(c)(4) 04/16/2024
Madrigal pharmaceuticals reports inducement grants under nasdaq listing rule 5635(c)(4) 04/03/2024
Madrigal pharmaceuticals announces pricing of upsized $600 million public offering 03/18/2024
Madrigal pharmaceuticals announces proposed public offering 03/18/2024
Madrigal pharmaceuticals announces fda approval of rezdiffra™ (resmetirom) for the treatment of patients with noncirrhotic nonalcoholic steatohepatitis (nash) with moderate to advanced liver fibrosis 03/14/2024
Madrigal pharmaceuticals reports inducement grants under nasdaq listing rule 5635(c)(4) 03/06/2024
Madrigal pharmaceuticals appoints mardi c. dier as chief financial officer 02/28/2024
Madrigal pharmaceuticals provides corporate updates and reports fourth quarter and full year 2023 financial results 02/28/2024
Madrigal pharmaceuticals reports inducement grants under nasdaq listing rule 5635(c)(4) 02/21/2024
Madrigal pharmaceuticals reports inducement grants under nasdaq listing rule 5635(c)(4) 02/06/2024
Madrigal pharmaceuticals announces additions to its leadership team 01/29/2024
Madrigal pharmaceuticals reports inducement grants under nasdaq listing rule 5635(c)(4) 01/22/2024
Madrigal pharmaceuticals presents five health economics outcomes research abstracts at the nash-tag annual conference 01/04/2024
Madrigal pharmaceuticals to present at the 42nd annual j.p. morgan healthcare conference 01/03/2024
Madrigal pharmaceuticals reports inducement grants under nasdaq listing rule 5635(c)(4) 12/22/2023
Madrigal pharmaceuticals reports inducement grants under nasdaq listing rule 5635(c)(4) 11/27/2023
Madrigal pharmaceuticals appoints ronald filippo as chief information officer 11/21/2023
Madrigal pharmaceuticals reports inducement grants under nasdaq listing rule 5635(c)(4) 11/15/2023
Madrigal pharmaceuticals appoints carole huntsman as chief commercial officer 11/10/2023
Madrigal pharmaceuticals provides corporate updates and reports third quarter 2023 financial results 11/06/2023
Madrigal pharmaceuticals reports inducement grants under nasdaq listing rule 5635(c)(4) 10/12/2023
Madrigal pharmaceuticals announces pricing of $500 million public offering 09/28/2023
Madrigal pharmaceuticals announces proposed public offering 09/28/2023
Madrigal pharmaceuticals reports inducement grants under nasdaq listing rule 5635(c)(4) 09/14/2023
Madrigal pharmaceuticals announces nda acceptance and priority review of the new drug application for resmetirom for the treatment of nash with liver fibrosis 09/13/2023
Madrigal pharmaceuticals appoints bill sibold as chief executive officer 09/11/2023
Madrigal pharmaceuticals provides corporate updates and reports second quarter 2023 financial results 08/08/2023
Madrigal pharmaceuticals completes submission of new drug application seeking accelerated approval of resmetirom for the treatment of nash with liver fibrosis 07/15/2023
Madrigal pharmaceuticals announces rolling submission of new drug application to u.s. fda seeking accelerated approval of resmetirom for the treatment of nash with liver fibrosis 06/30/2023
Madrigal pharmaceuticals presents phase 3 maestro-nash data during the opening general session of the easl congress™ 06/22/2023
Madrigal pharmaceuticals supports international nash day on june 8 06/06/2023
Madrigal pharmaceuticals provides corporate updates and reports first quarter 2023 financial results 05/09/2023
Madrigal pharmaceuticals provides corporate updates and reports 2022 fourth quarter and full year financial results 02/23/2023
Madrigal announces additional positive results from the pivotal phase 3 maestro-nash clinical trial of resmetirom for the treatment of nash with liver fibrosis 01/06/2023
Madrigal pharmaceuticals announces $300+ million in financing events to advance resmetirom program 12/21/2022
Madrigal pharmaceuticals to announce topline results from the phase 3 maestro-nash study of resmetirom on monday, december 19th 12/18/2022
Madrigal pharmaceuticals provides an overview of upcoming resmetirom data presentations and reports 2022 third quarter financial results 11/03/2022
Madrigal pharmaceuticals provides clinical and business updates and reports 2022 second quarter financial results 08/04/2022
Madrigal pharmaceuticals presents late-breaking phase 3 nash data and multiple oral abstracts at easl's international liver congress™ 06/25/2022
Madrigal pharmaceuticals supports international nash day on june 9 06/06/2022
Madrigal pharmaceuticals announces participation at three upcoming investor conferences 06/02/2022
Madrigal pharmaceuticals announces participation at two upcoming investor conferences 05/17/2022
Madrigal pharmaceuticals provides clinical and business updates and reports 2022 first quarter financial results 05/09/2022
Madrigal pharmaceuticals to present at the oppenheimer healthcare conference 03/09/2022
Madrigal pharmaceuticals provides business and clinical updates and reports 2021 fourth quarter and full year financial results 02/24/2022
Positive topline phase 3 maestro-nafld-1 data demonstrate resmetirom was safe, well-tolerated and provided statistically significant improvements in key measures of liver and cardiovascular health 01/31/2022
Madrigal pharmaceuticals to announce topline results from the phase 3 maestro-nafld-1 study of resmetirom on monday, january 31st 01/30/2022
Madrigal provides update on timeline for topline results from the phase 3 maestro-nafld-1 clinical trial of resmetirom 12/30/2021
Madrigal pharmaceuticals announces participation at two upcoming virtual investor conferences 11/23/2021
Madrigal pharmaceuticals provides corporate update and reports 2021 third quarter financial results 11/04/2021
Madrigal pharmaceuticals announces support of fatty liver foundation's screening fund to improve diagnosis and staging of non-alcoholic fatty liver disease (nafld) and non-alcoholic steatohepatitis (nash) 10/04/2021
Madrigal pharmaceuticals reports 2021 second quarter financial results and provides corporate update 08/05/2021
Robert waltermire joins madrigal pharmaceuticals as chief pharmaceutical development officer 08/02/2021
Madrigal pharmaceuticals offers patients resmetirom in a planned open label active treatment extension of the phase 3 maestro-nafld-1 clinical study 07/13/2021
Madrigal pharmaceuticals completes enrollment of the 52 week liver biopsy patient population in the phase 3 maestro-nash study of resmetirom 06/30/2021
Madrigal pharmaceuticals announces presentation of positive clinical data of resmetirom from open-label portion of ongoing phase 3 clinical trial maestro-nafld-1 at the international liver congress™ 2021 06/25/2021
Madrigal pharmaceuticals announces participation at two upcoming virtual investor conferences 06/08/2021
Madrigal pharmaceuticals to participate in ubs global healthcare virtual conference 05/21/2021
Alex howarth joins madrigal pharmaceuticals as chief financial officer 05/18/2021
Madrigal pharmaceuticals reports 2021 first quarter financial results and highlights 05/06/2021
Madrigal pharmaceuticals reports 2020 fourth quarter and full year financial results and highlights 02/25/2021
Madrigal pharmaceuticals highlights presentations at the liver meeting digital experience™, the american association for the study of liver diseases meeting november 13, 2020, including nash expert insights on the ongoing open label arm of resmetirom 52-w 11/13/2020
Madrigal pharmaceuticals highlights presentations at the liver meeting digital experience™, the american association for the study of liver diseases meeting november 13, 2020, including nash expert insights on the ongoing open label arm of resmetirom 52-week phase 3 maestro-nafld-1 trial 11/13/2020
Madrigal pharmaceuticals announces completion of enrollment in phase 3 maestro nafld-1 trial and reports 2020 third quarter financial results and highlights 11/05/2020
Terns pharmaceuticals to present clinical data on improved tern-101 tablet formulation at the paris nash digital experience 10/22/2020
Poxel dresse un bilan de ses activitÉs et publie sa position de trÉsorerie et son chiffre d’affaires du troisiÈme trimestre et des neuf premiers mois de 2020 10/20/2020
Terns pharmaceuticals to present positive data on single-agent and combination nash programs at the liver meeting® digital experience 2020 10/14/2020
Madrigal pharmaceuticals announces three abstracts accepted by the liver meeting digital experience™, the american association for the study of liver diseases meeting in november 2020, including positive data from ongoing open label arm of resmetirom 52 w 10/01/2020
Poxel announces positive results from phase 2a nash trial with pxl770, an oral first-in-class direct ampk activator 10/01/2020
Can-fite selected to deliver late-breaking oral presentation on namodenoson’s treatment of nash at american association for the study of liver diseases conference 09/30/2020
Covid-19 forces one of the biggest surges in technology investment in history, finds world’s largest technology leadership survey 09/22/2020
RÉsultats financiers du 1er semestre 2020 et point sur l’activitÉ 09/16/2020
Poxel publie ses rÉsultats financiers du premier semestre 2020 et dresse un bilan de ses activitÉs 09/15/2020
Enanta pharmaceuticals initiates phase 1 clinical study of edp-297, its highly potent and targeted follow-on farnesoid x receptor agonist for the treatment of non-alcoholic steatohepatitis 09/14/2020
Madrigal exceeds target enrollment in phase 3 maestro nafld-1 trial 09/03/2020
Madrigal pharmaceuticals exceeds target enrollment in phase 3 maestro nafld-1 trial 09/03/2020
Enanta pharmaceuticals presents new data from its hepatitis b and non-alcoholic steatohepatitis programs at the digital international liver congress™ 2020 08/28/2020
Can-fite reports second quarter 2020 financial results & provides clinical update 08/27/2020
Madrigal pharmaceuticals to present secondary analyses of data from phase 2 nash study of resmetirom and symposium at the digital international liver congress™ 2020 08/26/2020
Gilead announces presentation of more than 40 abstracts from extensive liver disease programs at the digital international liver congress™ 2020 08/25/2020
Global non-alcoholic steatohepatitis (nash) pipeline review, h2 2020 - researchandmarkets.com 08/24/2020
Terns pharmaceuticals appoints senthil sundaram as chief executive officer, mark vignola, ph.d., as chief financial officer, and erin quirk, m.d., as president 08/10/2020
Madrigal pharmaceuticals reports 2020 second quarter financial results and highlights 08/06/2020
Fractyl raises $55 million in series e financing to advance revita dmr for type 2 diabetes 08/06/2020
Merck and hanmi pharmaceutical enter into licensing agreement to develop efinopegdutide, an investigational once-weekly therapy for nonalcoholic steatohepatitis (nash) 08/04/2020
Enanta pharmaceuticals to present at the btig virtual biotechnology conference 2020 08/03/2020
Can-fite submits investigational new drug application to u.s. fda for covid-19 phase ii study 07/27/2020
Terns pharmaceuticals announces initiation of patient dosing in the lift study, a phase 2a clinical trial of tern-101 in development for nash 07/22/2020
Can-fite completes development of an assay to identify clinically active cannabis derived compounds 07/20/2020
Can-fite completes phase ii covid-19 protocol based on fda guidance, plans to file ind shortly 07/15/2020
Fda grants orphan drug designation for inflazome’s inzomelid for the treatment of cryopyrin-associated periodic syndromes (caps) 07/14/2020
89bio announces pricing of upsized public offering of common stock 07/08/2020
Poxel : nombre d’actions et de droits de vote composant le capital social 07/07/2020
Inventiva annonce la dÉcision de l’investigateur de rÉduire le nombre de patients dans l'Étude de phase ii en cours Évaluant lanifibranor chez des patients atteints de diabÈte de type 2 (t2dm) et de stÉatose hÉpatique non alcoolique (nafld) 07/06/2020
Abionyx pharma: monthly statement of total voting rights and shares forming the company’s share capital 07/02/2020
Investigation alert: the schall law firm announces it is investigating claims against intercept pharmaceuticals, inc. and encourages investors with losses of $100,000 to contact the firm 07/01/2020
Integrating echosens’ fibroscan into metaphy’s chronic care liver disease management program impacts patient outcomes, costs, financial performance of gastroenterology practices 06/29/2020
Poxel annonce les rÉsultats de son assemblÉe gÉnÉrale ordinaire annuelle et extraordinaire du 24 juin 2020 06/25/2020
Poxel announces positive pharmacokinetic (pk) / pharmacodynamic (pd) study results for pxl770, a direct ampk activator for the treatment of nash